CN101721683B - 人角质细胞生长因子1在制备治疗肛裂的药物中的应用 - Google Patents
人角质细胞生长因子1在制备治疗肛裂的药物中的应用 Download PDFInfo
- Publication number
- CN101721683B CN101721683B CN200910216185.9A CN200910216185A CN101721683B CN 101721683 B CN101721683 B CN 101721683B CN 200910216185 A CN200910216185 A CN 200910216185A CN 101721683 B CN101721683 B CN 101721683B
- Authority
- CN
- China
- Prior art keywords
- fgf7
- preparation
- anal
- anal fissure
- application according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910216185.9A CN101721683B (zh) | 2009-11-10 | 2009-11-10 | 人角质细胞生长因子1在制备治疗肛裂的药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910216185.9A CN101721683B (zh) | 2009-11-10 | 2009-11-10 | 人角质细胞生长因子1在制备治疗肛裂的药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101721683A CN101721683A (zh) | 2010-06-09 |
CN101721683B true CN101721683B (zh) | 2015-06-24 |
Family
ID=42443631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910216185.9A Active CN101721683B (zh) | 2009-11-10 | 2009-11-10 | 人角质细胞生长因子1在制备治疗肛裂的药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101721683B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102302770B (zh) * | 2011-08-08 | 2014-04-30 | 成都金凯生物技术有限公司 | 一种促进创面愈合的药物组合物 |
CN114292323A (zh) * | 2022-01-12 | 2022-04-08 | 中国医学科学院整形外科医院 | 一种角质细胞生长因子活性多肽及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1766107A (zh) * | 2005-07-22 | 2006-05-03 | 成都芝田生物工程有限公司 | 一种重组人角质细胞生长因子的生产方法 |
-
2009
- 2009-11-10 CN CN200910216185.9A patent/CN101721683B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1766107A (zh) * | 2005-07-22 | 2006-05-03 | 成都芝田生物工程有限公司 | 一种重组人角质细胞生长因子的生产方法 |
Non-Patent Citations (2)
Title |
---|
Biovitrum.Description.《KepivanceTM 》.2008,全文. * |
Hueber A.J., et al..Palifermin as treatment in dose-intense conventional polychemotherapy induced mucositis.《haematologica/ the hematology journal》.2006,第91卷(第1期),摘要、图1、表1及第91页. * |
Also Published As
Publication number | Publication date |
---|---|
CN101721683A (zh) | 2010-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hanft et al. | Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers | |
Yu et al. | In situ covalently cross-linked PEG hydrogel for ocular drug delivery applications | |
DK2621520T3 (en) | Collagenase G and collagenase H-compositions for the treatment of diseases involving changes of collagen | |
Zheng et al. | Controlled release of baricitinib from a thermos-responsive hydrogel system inhibits inflammation by suppressing JAK2/STAT3 pathway in acute spinal cord injury | |
JP2005508937A (ja) | 皮膚病変を治療するための方法および組成物 | |
RU2662564C2 (ru) | Лечение воспалительных заболеваний кожи | |
Yang et al. | Microenvironmentally optimized 3D-printed TGFβ-functionalized scaffolds facilitate endogenous cartilage regeneration in sheep | |
Yamamoto et al. | The acceleration of wound healing in primates by the local administration of immunostimulatory CpG oligonucleotides | |
Liu et al. | Bioinspired Andrias davidianus-Derived wound dressings for localized drug-elution | |
US20210038690A1 (en) | Promoting epithelial regeneration using heparin binding epidermal growth factor like growth factor | |
Rao et al. | Natural polymeric biomaterials in growth factor delivery for treating diabetic foot ulcers | |
Zhang et al. | Promoting effect of pomegranate peel extract on second-degree burn wound-healing through VEGF-A and TGF-β1 regulation | |
Yang et al. | Low intensity pulsed ultrasound influences the myogenic differentiation of muscle satellite cells in a stress urinary incontinence rat model | |
CN101721683B (zh) | 人角质细胞生长因子1在制备治疗肛裂的药物中的应用 | |
Han | Growth factor therapy | |
US20220064243A1 (en) | Agent for treatment of dermatological disorders | |
KR102026138B1 (ko) | Crif1 억제제를 함유하는 켈로이드 및 비후성 반흔 형성 억제 또는 치료용 조성물 | |
Shevtsov et al. | Glu-Trp-ONa or its acylated analogue (R-Glu-Trp-ONa) administration enhances the wound healing in the model of chronic skin wounds in rabbits | |
Liu et al. | Experimental study on the effect of chrysin on skin injury induced by amiodarone extravasation in rats | |
CN101721682B (zh) | 重组人成纤维细胞生长因子7突变体在制备治疗宫颈糜烂的药物中的应用 | |
WO2018038966A1 (en) | Pharmaceutical compositions for inducing phenotypic reversion of a cell and regeneration of compromised tissue | |
CN112023031A (zh) | SNase在制备促进糖尿病伤口愈合药物中的应用 | |
CN101721681A (zh) | 人角质细胞生长因子1在制备治疗糖尿病足部及腿部溃疡的药物中的应用 | |
Li et al. | New technologies and tissue repair and regeneration (2): Other biotherapeutic technologies | |
CN111249300B (zh) | 褪黑素联合甲钴胺在治疗糖尿病创面愈合障碍中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SUZHOU JINMENG BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: CHENGDU BOFA BIOTECHNOLOGY CO., LTD. Effective date: 20110322 Free format text: FORMER OWNER: TIBET TIANXING BIOPHARMACEUTICAL CO., LTD. TIANJIN BOFA BIOTECHNOLOGY CO., LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 610041 NO. 16, CHUANGYE ROAD, GAOXIN AVENUE, NEW AND HIGH TECHNOLOGY AREA, CHENGDU CITY, SICHUAN PROVINCE TO: 215425 XIANGTANG HEADQUARTERS, XIANGTANG HIGH TECHNOLOGY INDUSTRIAL PARK, GUIZHUANG, SHAXI TOWN, TAICANG CITY, SUZHOU CITY, JIANGSU PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110322 Address after: Shaxi city Taicang town Suzhou city Jiangsu province 215425 Guizhuang Xiangtang High-tech Industrial Park Hong Tong headquarters Applicant after: Suzhou Genemen Biotech Co., Ltd. Address before: 610041, 16, hi tech Road, hi tech Zone, Sichuan, Chengdu Applicant before: Chengdu Bofa Biotechnology Co., Ltd. Co-applicant before: Tianjin Bofa Biotechnology Co., Ltd. Co-applicant before: Xizang Tianxing Biomedical Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: Shaxi city Taicang town Suzhou city Jiangsu province 215425 Guizhuang Xiangtang High-tech Industrial Park Hong Tong headquarters Patentee after: Xinlitai (Suzhou) Pharmaceutical Co., Ltd. Address before: Shaxi city Taicang town Suzhou city Jiangsu province 215425 Guizhuang Xiangtang High-tech Industrial Park Hong Tong headquarters Patentee before: Suzhou Genemen Biotech Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder |